Genenta Science is a biotechnology company that develops gene transfer therapy for the treatment of cancer tumors. Founded by Bernhard Gentner, Luigi Naldini, and Pierluigi Paracchi in 2014, Genenta Science is backed by investors that include Club degli Investitori, Qianzhang Investment, and VENTURE CAPITAL POST and is headquartered in Milano.